Source: Ophthalmology
Area: News
The results of a cross-sectional study that found an association between daily aspirin use and AMD have been published in Ophthalmology.
The authors note that associations between aspirin use and agi…
Author: NeLM - Ophthalmology
Interventions to slow progression of myopia in children
Source: Cochrane Library
Area: Evidence > Disease Focused Reviews
Background
Nearsightedness (myopia) causes blurry vision when looking at distant objects. Highly nearsighted people are at greater risk of several vision-threatening problems su…
Determination of seasonal allergic conjunctivitis variation using internet search engine data
Source: Eye
Area: Evidence > Medicines Management > References
Letter reporting the use of a validated method of identifying periods of high disease activity to describe the seasonal pattern of seasonal allergic rhinoconjunctivitis (SAR) in th…
SMC does not recommend dexamethasone intravitreal implant (Ozurdex®) for macular oedema following retinal vein occlusion
Source: Scottish Medicines Consortium (SMC)
Area: Evidence > Drug Specific Reviews
Following consideration of a resubmission, the Scottish Medicines Consortium (SMC) still does not recommend dexamethasone intravitreal implant (Ozurdex®) for use w…
Letter to NEJM: Safe preparation and administration of intravitreal bevacizumab injections
Source: N Engl J Med
Area: News
Following the publication of a study by the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT) research group (see link to NeLM report) in the New England Journal of Medicine (May 19) supporting off-…
Further data for aflibercept in neovascular age-related macular degeneration
Source: BioSpace
Area: News
BioSpace has reported on the results of an integrated analysis of two Phase III studies (VIEW 1 and VIEW 2) of aflibercept intravitreal injection in the treatment of neovascular age-related macular degeneration (wet AMD).&…
NICE published costing statement for its guidance on ranibizumab for diabetic macular oedema
Source: NICE
Area: News
NICE has published guidance recommending against the use of ranibizumab within the NHS for the treatment of visual impairment due to diabetic macular oedema (TAG 237; see link below).
A costing statement publi…
NICE issues guidance on ranibizumab for the treatment of diabetic macular oedema
Source: NICE
Area: Evidence > Guidelines
NICE has published guidance (Technology Appraisal Guidance 237) recommending against the use of ranibizumab within the NHS for the treatment of visual impairment due to diabetic macular oedema. Those …
NICE issues Appraisal Consultation Document on ranibizumab for the treatment of macular oedema due to retinal vein occlusion
Source: NICE
Area: News
The National Institute for Health and Clinical Excellence (NICE) has issued an appraisal consultation document for the use of ranibizumab for macular oedema due to retinal vein occlusion, and makes the following preliminary rec…
Horizon scanning: US FDA approves aflibercept (Eylea®) for wet age-related macular degeneration
Source: FDA
Area: News
The US FDA has approved aflibercept (Eylea®) for the treatment of wet (neovascular) age-related macular degeneration (AMD). Aflibercept is administered as an intravitreal injection (given by an ophthalmologist) every 4-8 …
European CHMP adopts positive opinion on new indication for nepafenac (Nevanac)
Source: European Medicines Agency
Area: News
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion on a new indication for nepafenac (Nevanac) as follows:
“Reduction in t…
Melatonin for non-respiratory sleep disorders in visually impaired children
Source: Cochrane Library
Area: Evidence > Drug Specific Reviews
Background
Exogenous melatonin helps in regulating the circadian rhythm and is widely used for the management of sleep disorders in visually impaired children.
Ob…
Melatonin for non-respiratory sleep disorders in visually impaired children
Source: Cochrane Library
Area: Evidence > Drug Specific Reviews
Background
Exogenous melatonin helps in regulating the circadian rhythm and is widely used for the management of sleep disorders in visually impaired children.
Ob…
Melatonin for non-respiratory sleep disorders in visually impaired children
Source: Cochrane Library
Area: Evidence > Drug Specific Reviews
Background
Exogenous melatonin helps in regulating the circadian rhythm and is widely used for the management of sleep disorders in visually impaired children.
Ob…
FDA requests further data on Iluvien® (fluocinolone acetonide intravitreal implant) for diabetic macular oedema
Source: BioSpace
Area: News
According to BioSpace, the US FDA has issued a complete response letter regarding a New Drug Application (NDA) for Iluvien® (fluocinolone acetonide) for the treatment of diabetic macular oedema associated with diabetic re…
Role of the community pharmacist in the management of ophthalmology patients
Source: Journal Francais de l’Ophtalmologie
Area: Evidence > Medicines Management > References
Objectives: To assess the role of community pharmacists in ophthalmology, to evaluate the frequency of giving patients advice, and to report their d…
SMC accepts ranibizumab (Lucentis®) for restricted use in the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion
Source: Scottish Medicines Consortium (SMC)
Area: Evidence > Drug Specific Reviews
The Scottish Medicines Consortium has accepted ranibizumab (Lucentis®) for restricted use within NHS Scotland for the treatment of adults with macular oedema secon…
Interventions for visual field defects in patients with stroke
Source: Cochrane Library
Area: Evidence > Disease Focused Reviews
Background
Visual field defects are estimated to affect 20% to 57% of people who have had a stroke. Visual field defects can affect functional ability in activities of daily living …
Interventions for disorders of eye movement in patients with stroke
Source: Cochrane Library
Area: Evidence > Disease Focused Reviews
Background
Eye movement disorders may affect over 70% of stroke patients. These eye movement disorders can result in difficulty maintaining the normal ocular position and difficulty…
Review: Panretinal photocoagulation for proliferative diabetic retinopathy
Source: N Engl J Med
Area: News
This review of panretinal photocoagulation for proliferative diabetic retinopathy begins with a case vignette, followed by a discussion of the clinical problem, pathophysiology and effect of therapy, clinical evidence, …